Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Br J Haematol. 2009 Aug 31;147(4):507–514. doi: 10.1111/j.1365-2141.2009.07881.x

Figure 2.

Figure 2

Percentage of HDAC Inhibition in Peripheral White Blood Cells or in Bone Marrow from CLL Patients After MGCD0103 Treatment (Day 8). Each dot represents a patient. Black line: average. Dotted line: 20% inhibition.